Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | AMGN | CELG | GILD | BIIB |
| Company | Blueprint Medicines Corp | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 108.71 | 312.89 | 108.01 | 64.72 | 222.76 |
| High | 109.02 | 314.89 | 108.59 | 66.20 | 223.95 |
| Low | 106.01 | 309.82 | 107.27 | 64.67 | 220.01 |
| Last | 106.70 | 310.15 | 108.24 | 65.96 | 221.50 |
| Change | -1.64 | -2.71 | +0.11 | +1.38 | -1.25 |
| % Change | -1.51% | -0.87% | +0.10% | +2.14% | -0.56% |
| Volume | 406,700 | 2,611,800 | 191,230,496 | 8,733,200 | 655,100 |
| 20-Day Average Volume | 744,180 | 2,930,860 | 16,188,930 | 7,614,375 | 1,327,535 |
| Previous Close | 108.34 | 312.86 | 108.13 | 64.58 | 222.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 96.32 | 281.61 | 108.17 | 65.99 | 207.57 |
| 20-Day Raw Stochastic | 84.10% | 79.89% | 63.25% | 39.52% | 92.90% |
| 20-Day Relative Strength | 64.67% | 65.95% | 64.69% | 39.82% | 58.34% |
| Weighted Alpha | +114.21 | +34.03 | +46.30 | -19.29 | -26.00 |
| Today's Opinion | 100% Buy | 56% Buy | 100% Buy | 100% Sell | 56% Sell |
| Previous Opinion | 100% Buy | 56% Buy | 100% Buy | 100% Sell | 56% Sell |
| Last Month's Opinion | 100% Buy | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.46% since 05/03/24 | -0.37% since 05/03/24 | -1.97% since 11/13/19 | +1.82% since 05/03/24 | +1.83% since 05/03/24 |
| Low | 103.31 on 05/07/24 | 297.52 on 05/06/24 | 107.27 on 11/20/19 | 64.34 on 05/06/24 | 216.08 on 05/07/24 |
| High | 109.87 on 05/09/24 | 314.89 on 05/10/24 | 110.53 on 11/14/19 | 66.20 on 05/10/24 | 223.95 on 05/10/24 |
| 1-Month | |||||
| %Chg | +17.91% since 04/10/24 | +16.40% since 04/10/24 | +5.14% since 10/18/19 | -3.17% since 04/10/24 | +9.90% since 04/10/24 |
| Low | 84.33 on 04/15/24 | 260.68 on 04/19/24 | 102.40 on 10/21/19 | 64.33 on 05/03/24 | 189.44 on 04/19/24 |
| High | 110.93 on 05/03/24 | 322.60 on 05/03/24 | 110.70 on 11/13/19 | 69.03 on 04/11/24 | 223.95 on 05/10/24 |
| 3-Month | |||||
| %Chg | +39.40% since 02/09/24 | +6.54% since 02/09/24 | +13.63% since 08/20/19 | -10.47% since 02/09/24 | -8.08% since 02/09/24 |
| Low | 72.24 on 02/14/24 | 260.68 on 04/19/24 | 93.41 on 08/23/19 | 64.33 on 05/03/24 | 189.44 on 04/19/24 |
| High | 110.93 on 05/03/24 | 322.60 on 05/03/24 | 110.70 on 11/13/19 | 76.21 on 03/11/24 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | +81.31% since 11/10/23 | +16.03% since 11/10/23 | +14.14% since 05/20/19 | -13.12% since 11/10/23 | -1.46% since 11/10/23 |
| Low | 56.74 on 11/13/23 | 260.52 on 11/21/23 | 89.08 on 07/23/19 | 64.33 on 05/03/24 | 189.44 on 04/19/24 |
| High | 110.93 on 05/03/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,630,408 | 167,829,040 | 77,035,920 | 80,407,072 | 32,431,732 |
| Shares Outstanding, K | 61,200 | 536,435 | 711,714 | 1,245,077 | 145,597 |
| Annual Sales | 249,380,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | -506,980,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 96,120,000 | 7,447,000,000 | 4,520,000,000 | 6,686,000,000 | 2,290,500,000 |
| Last Quarter Net Income | 89,140,000 | -113,000,000 | 1,691,000,000 | -4,170,000,000 | 393,400,000 |
| 60-Month Beta | 0.65 | 0.60 | 1.41 | 0.22 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.32 on 05/02/24 | 3.96 on 05/02/24 | 2.99 on 10/31/19 | -1.32 on 04/25/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 10/31/19 | 04/25/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 10.99 | 16.11 | 14.65 |